A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.

about

Immunotherapy for head and neck cancer patients: shifting the balance.Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer.Therapeutic vaccination targeting the tumour vasculature.Emerging human papillomavirus vaccines

P2860

Q38068966-8E944CF9-30C7-4036-909E-7BC8FC5E9F7B Q38089937-E817199A-118B-43F5-A2E6-13F7CC6B4A40 Q38268464-4D64B7B0-DEA1-45ED-953B-3607E5D603E9 Q56967486-D5DFCFF5-A494-470E-BBF4-665048382D58

P2860

A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.

Item

http://www.wikidata.org/entity/Q38006991

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

A prophylactic quadrivalent va ...... ed to HPV-6, -11, -16 and -18.

@en

type

Item

label

A prophylactic quadrivalent va ...... ed to HPV-6, -11, -16 and -18.

@en

prefLabel

A prophylactic quadrivalent va ...... ed to HPV-6, -11, -16 and -18.

@en

P1476

A prophylactic quadrivalent va ...... ed to HPV-6, -11, -16 and -18.

@en

P2093

Scott Vuocolo

http://www.w3.org/2001/XMLSchema#string

Stephen E Goldstone

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

Trends in the incidence of invasive and in situ vulvar carcinoma

Global cancer statistics, 2002

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Classification of papillomaviruses

P304

395-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.12.20

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224886870

http://www.w3.org/2001/XMLSchema#string

P698

22551023

http://www.w3.org/2001/XMLSchema#string

A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.

about

P2860

P2860

A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698